Chemical Structure : Tarlatamab
Catalog No.: PC-38870Not For Human Use, Lab Use Only.
Tarlatamab (AMG 757) is a half-life extended bispecific T-cell engager (BiTE) molecule targeting delta-like ligand 3 (DLL3), a target that is selectively expressed in SCLC tumors, but with minimal normal tissue expression.
Packing | Price | Stock | Quantity |
---|---|---|---|
1 mg | Get quote | ||
5 mg | Get quote | ||
10 mg | Get quote | ||
25 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tarlatamab (AMG 757) is a half-life extended bispecific T-cell engager (BiTE) molecule targeting delta-like ligand 3 (DLL3), a target that is selectively expressed in SCLC tumors, but with minimal normal tissue expression.
AMG 757 showed potent and specific killing of even those SCLC cell lines with very low DLL3 expression (<1,000 molecules per cell).
AMG 757 effectively engaged systemically administered human T cells, induced T-cell activation, and redirected T cells to lyse tumor cells to promote significant tumor regression and complete responses in PDX models of SCLC and in orthotopic models of established primary lung SCLC and metastatic liver lesions.
Isotype: Immunoglobulin scFv-scFv-scFc.
Anti-[huuman DLL3 (deltalike ligand 3)] and anti-[human CD3E (CD3 epsilon, Leu-4)], monoclonal antibody single chain (scFv)2-scFc, bispecific.
M.Wt | ||
Formula | ||
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright